Nile Pharmaceuticals results, Fiscal year 2021
Net profit, assets, equity and cash flow for Fiscal year 2021, against the same period a year earlier, from the published financial statements. fiscal year starts in July.
Net profit64.42 millionEGP
Total assets720 millionEGP
Shareholders' equity371 millionEGP
Operating cash flow79.47 millionEGP
In short
- Nile Pharmaceuticals's net profit for Fiscal year 2021 was about 64.42 million EGP.
- Total assets at the end of Fiscal year 2021 were about 720 million EGP, and shareholders' equity about 371 million EGP.
- Operating cash flow for Fiscal year 2021 was positive at 79.47 million EGP.
Key lines against the same period a year earlier
This periodYear earlierChange
Net profit64.42 million——
Gross profit502 million——
Total assets720 million——
Total liabilities349 million——
Shareholders' equity371 million——
Total liabilities and equity720 million——
Operating cash flow79.47 million——
Investing cash flow-4.29 million——
Financing cash flow-45.2 million——
Net change in cash29.99 million——
Figures in EGP from the published statement summaries (consolidated where the company publishes consolidated statements), after normalising reporting units across periods. The exact figure is in the attached report, which may be the standalone version.
Nile Pharmaceuticals's Q1 2027 results, the day they are published
One email on the day, no account, and a one-click stop in the email itself.
By subscribing you agree to receive these alerts only. Privacy policy